The prostate cancer treatment landscape is undergoing a significant transformation, according to a landmark editorial in the New England Journal of Medicine. Rather than relying on traditional sequential approaches—where surgery or radiation precedes systemic therapy—emerging evidence supports integrating systemic treatments directly around the time of definitive local intervention.
This watershed moment represents decades of established practice being challenged by new clinical data. Experts suggest that this perioperative approach could fundamentally improve outcomes for men facing prostate cancer surgery or radiation therapy. The shift reflects a broader evolution in oncology, where the timing and coordination of multiple treatment modalities are proving increasingly critical to patient success.
The implications are substantial, with potential to influence treatment protocols for thousands of patients annually across the globe. Read the full article on GMJ Newsroom.
Was this article helpful?
